The Limited Times

Now you can see non-English news...

At the Stade de France vaccinodrome, Moderna's strange unpopularity

2021-04-05T21:22:52.387Z


The slots reserved on Doctolib show a huge difference between the appointments stormed for Pfizer doses and those for p


This is unexpected data for health professionals working at the Stade de France vaccine park, in Saint-Denis (Seine-Saint-Denis), which will officially open to the public this Tuesday morning.

A few hours before its commissioning, there are still a lot of slots on Doctolib.fr for people wishing to be vaccinated from day one.

But it is above all the enormous imbalance between the doses of Pfizer and those of Moderna, which surprises the managers of the site.

READ ALSO>

Opening of the giant vaccinodrome at the Stade de France this Tuesday: six questions that we ask ourselves


While for Pfizer, there are no more slots available until the end of the week, for Moderna, several hundred options remain available for the public, from Tuesday noon to Saturday afternoon.

“Without being able to explain it, Moderna clearly has a popularity deficit, observes Katy Bontinck, first deputy (Generation. S) to the mayor of Saint-Denis, in charge of health.

Perhaps because it has been less used in France so far and therefore, it is less known?

»She asks herself.

An amalgamation with AstraZeneca?

However, the technique (RNA-Messenger) and the efficacy (94% for Moderna, against 94.5% for Pfizer) are completely comparable between the two vaccines.

Would the public make an amalgamation between Moderna and AstraZeneca, whose vaccine had been suspended for several days by many European countries, in mid-March?

This weekend, while the European Medicines Agency confirmed a few days ago a "rare" risk of thrombosis after the administration of the vaccine, nearly 1,200 doses of AstraZeneca were thus shunned in the North. Pas-de-Calais.

READ ALSO>

At the Stade de France, in order not to lose doses, we will vaccinate sixty-year-olds from Seine-Saint-Denis this week


“The ARS

(Editor's note: the regional health agency)

tells us that Moderna also ends in A, like AstraZeneca… notes Katy Bontinck.

It can play out a few things but what is certain is that the choice of vaccine seems very important in the eyes of the public.

We also hear people say that the Janssen vaccine is coming, that there is only one dose and no known side effects. ”

In the corridors of the Stade de France, the data is of some concern to the teams in charge of opening the vaccinodrome.

"We do not know what is happening but it is quite incredible the difference in speed at which the doses leave compared to Pfizer", we whisper to the departmental council of Seine-Saint-Denis.

Elected officials have already seized the ARS to ask it to communicate on the subject very quickly.

Source: leparis

All news articles on 2021-04-05

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.